Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
Adrenal suppression effects of corticosteroids are among the most important safety concerns
for this group of products. This study is designed to determine the adrenal effects of the
investigational formulation of 122-0551 and characterize the steady state pharmacokinetics of
the formulation.